Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B Jan 19, 2017
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease Jan 3, 2017
Abeona Therapeutics to Present at 2016 Genetic Rx Boston Biotech Conference at Harvard Medical School Dec 6, 2016
Abeona Therapeutics Announces Third Quarter 2016 Financial Results and Recent Clinical Highlights Nov 10, 2016
Abeona Therapeutics to Present at Alliance of Regenerative Medicine 4th Annual Advanced Therapies Investor Day in London, UK Nov 3, 2016
Abeona Therapeutics Announces JAMA Publication of Positive Phase 1 Study Results for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa Nov 2, 2016
